|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/22 Goldenwell Biotech, Inc. 10-Q 6/30/22 40:1.6M Discount Edgar/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 452K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 13K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 13K
11: R1 Cover HTML 62K
12: R2 Balance Sheet HTML 74K
13: R3 Balance Sheet (Parenthetical) HTML 21K
14: R4 Statement of Operations (Unaudited) HTML 62K
15: R5 Statement of Changes in Stockholders' Equity HTML 47K
(Unaudited)
16: R6 Statement of Cash Flows (Unaudited) HTML 57K
17: R7 Organization and Description of Business HTML 16K
18: R8 Going Concern HTML 16K
19: R9 Summary of Significant Accounting Policies HTML 21K
20: R10 Lease Accounting HTML 17K
21: R11 Related Party Transaction HTML 16K
22: R12 Income Taxes HTML 28K
23: R13 Stockholders Equity HTML 21K
24: R14 Subsequent Events HTML 15K
25: R15 Summary of Significant Accounting Policies HTML 33K
(Policies)
26: R16 Income Taxes (Tables) HTML 26K
27: R17 Organization and Description of Business (Details HTML 14K
Narrative)
28: R18 Going Concern (Details Narrative) HTML 16K
29: R19 Summary of Significant Accounting Policies HTML 16K
(Details Narrative)
30: R20 Lease Accounting (Details Narrative) HTML 28K
31: R21 Related Party Transaction (Details Narrative) HTML 17K
32: R22 Income Taxes (Details) HTML 21K
33: R23 Income Taxes (Details 1) HTML 19K
34: R24 Income Taxes (Details Narrative) HTML 20K
35: R25 Stockholders Equity (Details Narrative) HTML 28K
38: XML IDEA XML File -- Filing Summary XML 62K
36: XML XBRL Instance -- gdwl_10q_htm XML 253K
37: EXCEL IDEA Workbook of Financial Reports XLSX 44K
8: EX-101.CAL XBRL Calculations -- gdwl-20220630_cal XML 68K
10: EX-101.DEF XBRL Definitions -- gdwl-20220630_def XML 96K
7: EX-101.LAB XBRL Labels -- gdwl-20220630_lab XML 292K
9: EX-101.PRE XBRL Presentations -- gdwl-20220630_pre XML 224K
6: EX-101.SCH XBRL Schema -- gdwl-20220630 XSD 62K
39: JSON XBRL Instance as JSON Data -- MetaLinks 133± 176K
40: ZIP XBRL Zipped Folder -- 0001477932-22-006072-xbrl Zip 81K
EXHIBIT 32.2
SECTION 906 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF
GOLDENWELL BIOTECH, INC.
In connection with the accompanying Quarterly Report on Form 10-Q of Goldenwell Biotech, Inc. for the quarter ended June 30, 2022, the undersigned, Hua Xie, Secretary of Goldenwell Biotech, Inc., does hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) |
such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
|
| (2) | the information contained in such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 fairly presents, in all material respects, the financial condition and results of operations of Goldenwell Biotech, Inc. |
| Date: August 15, 2022 |
|
/s/ Hua Xie |
|
|
|
| Name: Hua Xie |
|
|
|
| Secretary: Secretary |
|
|
|
| (principal accounting officer and principal financial officer) |
|
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/15/22 | None on these Dates | ||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/21/20 Goldenwell Biotech, Inc. S-1 5:962K West Coast Stock… Inc/FA |